Zymeworks (ZYME) Misses Q2 EPS by 25c

Zymeworks (NASDAQ: ZYME) reported Q2 EPS of ($0.62), $0.25 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $19.1 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• S&P announces major changes in S&P 100, S&P 500, S&P 400
• Honeywell Aerospace (HONA) dropped from S&P 100